Endocyte Inc (ECYT.OQ)
13 Jul 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2011||Independent Chairman of the Board|
|50||2017||President, Chief Executive Officer, Director|
|44||2017||Chief Financial Officer|
|67||1998||Chief Science Officer, Director|
|51||2013||Vice President - Quality|
- BRIEF-Endocyte Reports Q1 Loss Per Share $0.16
- BRIEF-Endocyte Says Data Presented At AACR Show That EC17 Penetrates Solid Tumors Within Minutes And Is Retained Due To High Affinity For Folate Receptor
- BRIEF-Endocyte Nominates Dawn Svoronos For Election To Its Board
- BRIEF-Endocyte Says In Connection With Machado's Election, Board Increased Size To 11 Members
- BRIEF-Endocyte Announces Proposed Public Offering Of Common Stock